Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 23, Issue 4, Pages 1232-1241
Publisher
Informa UK Limited
Online
2015-12-24
DOI
10.3109/10717544.2015.1124472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapies for triple negative breast cancer
- (2015) Eleni Andreopoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials
- (2015) Meiyuan Xing et al. PLoS One
- Breast Cancer: Epidemiology and Etiology
- (2014) ZiQi Tao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
- (2014) Jing Yao et al. International Journal of Nanomedicine
- Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: Preparation, characterization and antitumor activity
- (2014) Ketan Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER Consortium
- (2014) Julie R. Palmer et al. JNCI-Journal of the National Cancer Institute
- Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
- (2014) M. Bonotto et al. ONCOLOGIST
- Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid
- (2014) Chandraiah Godugu et al. PLoS One
- Mir-34: A New Weapon Against Cancer?
- (2014) Gabriella Misso et al. Molecular Therapy-Nucleic Acids
- Gambogic acid inhibits angiogenesis through inhibiting PHD2–VHL–HIF-1α pathway
- (2013) Na Lu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Medium Chain Triglyceride (MCT) Rich, Paclitaxel Loaded Self Nanoemulsifying Preconcentrate (PSNP): A Safe and Efficacious Alternative to Taxol®
- (2013) Ketan Patel et al. Journal of Biomedical Nanotechnology
- Overexpression of microRNA-122 enhances in vitro hepatic differentiation of fetal liver-derived stem/progenitor cells
- (2013) Ravi Doddapaneni et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Current trends in the use of liposomes for tumor targeting
- (2013) Pranali P Deshpande et al. Nanomedicine
- Challenges in Development of Targeted Liposomal Therapeutics
- (2012) Rupa R. Sawant et al. AAPS Journal
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
- (2012) F. Andre et al. ANNALS OF ONCOLOGY
- Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
- (2012) Xu Wang et al. Anti-Cancer Agents in Medicinal Chemistry
- Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells
- (2012) Chenglin Li et al. Biochemistry and Cell Biology
- Enhancement of Anticancer Efficacy of Chemotherapeutics by Gambogic Acid Against Gastric Cancer Cells
- (2012) Zheng-Yun Zou et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway
- (2011) Chenglin Li et al. BIOCHEMICAL PHARMACOLOGY
- Apoptosis: A Programme of Cell Death or Cell Disposal?
- (2011) W. O. Pereira et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells
- (2009) Hongyan Gu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The mitochondrial p53 pathway
- (2008) Angelina V. Vaseva et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials
- (2008) Rajesh Naithani et al. CURRENT MEDICINAL CHEMISTRY
- Studies on the toxicity of gambogic acid in rats
- (2008) Qi Qi et al. JOURNAL OF ETHNOPHARMACOLOGY
- Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis
- (2008) Qi Qi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
- (2008) Dayong Zhai et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started